104 related articles for article (PubMed ID: 8811337)
21. Potential impact of viral load and genetic makeup of HIV type 1 on mother-to-child transmission: characterization of env-C2V3C3 and nef sequences.
Pádua E; Parreira R; Tendeiro R; Nunes B; Castela J; Soares I; Mouzinho A; Reis E; Paixão MT
AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1171-7. PubMed ID: 19886833
[TBL] [Abstract][Full Text] [Related]
22. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.
Singh DK; McCormick C; Pacyniak E; Lawrence K; Dalton SB; Pinson DM; Sun F; Berman NE; Calvert M; Gunderson RS; Wong SW; Stephens EB
Virology; 2001 Mar; 282(1):123-40. PubMed ID: 11259196
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
Li Y; Kappes JC; Conway JA; Price RW; Shaw GM; Hahn BH
J Virol; 1991 Aug; 65(8):3973-85. PubMed ID: 1830110
[TBL] [Abstract][Full Text] [Related]
26. Sequence analysis of the V3 loop regions of the env genes of Ugandan human immunodeficiency proviruses.
Oram JD; Downing RG; Roff M; Serwankambo N; Clegg JC; Featherstone AS; Booth JC
AIDS Res Hum Retroviruses; 1991 Jul; 7(7):605-14. PubMed ID: 1768462
[TBL] [Abstract][Full Text] [Related]
27. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
28. Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.
Ball JK; Holmes EC; Whitwell H; Desselberger U
J Gen Virol; 1994 Apr; 75 ( Pt 4)():67-79. PubMed ID: 8151287
[TBL] [Abstract][Full Text] [Related]
29. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
Poon B; Chang MA; Chen IS
J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
[TBL] [Abstract][Full Text] [Related]
30. Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells.
Kishi M; Zheng YH; Bahmani MK; Tokunaga K; Takahashi H; Kakinuma M; Lai PK; Nonoyama M; Luftig RB; Ikuta K
J Virol; 1995 Dec; 69(12):7507-18. PubMed ID: 7494257
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines.
Maitra RK; Ahmad N; Holland SM; Venkatesan S
Virology; 1991 Jun; 182(2):522-33. PubMed ID: 2024488
[TBL] [Abstract][Full Text] [Related]
32. An individual with a high prevalence of a tat-defective provirus in peripheral blood.
Sabino E; Cheng-Mayer C; Mayer A
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1265-8. PubMed ID: 8142143
[TBL] [Abstract][Full Text] [Related]
33. Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates.
McNearney T; Hornickova Z; Templeton A; Birdwell A; Arens M; Markham R; Saah A; Ratner L
Virology; 1995 Apr; 208(1):388-98. PubMed ID: 11831726
[TBL] [Abstract][Full Text] [Related]
34. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
Kuiken CL; de Jong JJ; Baan E; Keulen W; Tersmette M; Goudsmit J
J Virol; 1992 Sep; 66(9):5704. PubMed ID: 1501303
[No Abstract] [Full Text] [Related]
35. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.
Antell GC; Dampier W; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; Schwartz G; Hershberg U; Krebs FC; Wigdahl B
Retrovirology; 2016 May; 13(1):32. PubMed ID: 27143130
[TBL] [Abstract][Full Text] [Related]
36. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
[TBL] [Abstract][Full Text] [Related]
37. V3 sequences in primary HIV-1 infection.
Antonioli IM; Baumberger C; Yerly S; Perrin L
AIDS; 1995 Jan; 9(1):11-7. PubMed ID: 7893436
[TBL] [Abstract][Full Text] [Related]
38. Intragenic proviral elements support transcription of defective HIV-1 proviruses.
Kuniholm J; Armstrong E; Bernabe B; Coote C; Berenson A; Patalano SD; Olson A; He X; Lin NH; Fuxman Bass JI; Henderson AJ
PLoS Pathog; 2021 Dec; 17(12):e1009982. PubMed ID: 34962974
[TBL] [Abstract][Full Text] [Related]
39. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
40. Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution.
Kuiken CL; Cornelissen MT; Zorgdrager F; Hartman S; Gibbs AJ; Goudsmit J
J Gen Virol; 1996 Apr; 77 ( Pt 4)():783-92. PubMed ID: 8627267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
